Free Trial
NASDAQ:REVB

Revelation Biosciences (REVB) Stock Price, News & Analysis

Revelation Biosciences logo
$2.83 +0.32 (+12.75%)
As of 03:31 PM Eastern

About Revelation Biosciences Stock (NASDAQ:REVB)

Key Stats

Today's Range
$2.37
$2.92
50-Day Range
$2.24
$9.78
52-Week Range
$2.11
$168.00
Volume
782,957 shs
Average Volume
131,338 shs
Market Capitalization
$4.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Revelation Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

REVB MarketRank™: 

Revelation Biosciences scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Revelation Biosciences.

  • Earnings Growth

    Earnings for Revelation Biosciences are expected to grow in the coming year, from ($49.33) to ($34.03) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Revelation Biosciences is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Revelation Biosciences is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Revelation Biosciences has a P/B Ratio of 0.10. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Revelation Biosciences' valuation and earnings.
  • Percentage of Shares Shorted

    7.54% of the float of Revelation Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Revelation Biosciences has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Revelation Biosciences has recently increased by 10.95%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Revelation Biosciences does not currently pay a dividend.

  • Dividend Growth

    Revelation Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.54% of the float of Revelation Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Revelation Biosciences has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Revelation Biosciences has recently increased by 10.95%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Revelation Biosciences has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Revelation Biosciences this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Revelation Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.30% of the stock of Revelation Biosciences is held by insiders.

  • Percentage Held by Institutions

    Only 12.80% of the stock of Revelation Biosciences is held by institutions.

  • Read more about Revelation Biosciences' insider trading history.
Receive REVB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Revelation Biosciences and its competitors with MarketBeat's FREE daily newsletter.

REVB Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

REVB Stock Analysis - Frequently Asked Questions

Revelation Biosciences' stock was trading at $22.1280 at the start of the year. Since then, REVB shares have decreased by 87.7% and is now trading at $2.7210.

Revelation Biosciences, Inc. (NASDAQ:REVB) posted its earnings results on Thursday, May, 8th. The company reported ($6.33) EPS for the quarter, beating analysts' consensus estimates of ($20.64) by $14.31.

Revelation Biosciences shares reverse split on Tuesday, January 28th 2025.The 1-16 reverse split was announced on Friday, January 24th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Shares of REVB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Revelation Biosciences investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), Wayfair (W), Abbott Laboratories (ABT), JPMorgan Chase & Co. (JPM) and Bank of America (BAC).

Company Calendar

Last Earnings
5/08/2025
Today
7/09/2025
Next Earnings (Estimated)
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:REVB
CIK
1810560
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.04 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$27.05 per share
Price / Book
0.09

Miscellaneous

Free Float
1,499,000
Market Cap
$3.67 million
Optionable
Not Optionable
Beta
-0.08
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:REVB) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners